US 7211599
Use of etodolac to treat hyperplasia
granted A61KA61K31/12A61K31/18
Quick answer
US patent 7211599 (Use of etodolac to treat hyperplasia) held by The Regents of the University of California expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue May 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/12, A61K31/18, A61K31/40, A61K31/407